Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREtreatment of Cilostazol Loading in Elective Percutaneous Coronary Intervention to Decrease Adverse Events

NCT00938522 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT00938522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00938522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREtreatment of Cilostazol Loading in Elective Percutaneous Coronary Intervention to Decrease Adverse Events
Lead sponsor
Samsung Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2009
Completion date
October 31, 2011
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angioplasty, transluminal, percutaneous coronary